2. Pertussis is an acute respiratory tract infection
caused by Bordetella pertussis
Characterized by intense spasmodic cough
"whoop.“
Sydenham first used the term pertussis (intense
cough) in 1670
worldwide prevalence is decreased by active
immunization
3. Continues to be public health concern even in
countries with high immunization coverage
About 1.29 lac cases were reported to WHO
globally, in 2010
In India ,marked decline in incidence occurred
after launch of UIP ( 1.63 lac cases in 1987 vs
only 39,091 cases in 2011; 76% decrease)
4. DROPLETS
Highly contagious,almost 100% in susceptible
host(under fives)
Undiagnosed adults may be a source when source
is not obvious
Do not survive in dust for too long
5. Bordetella pertussis is the sole cause of epidemic pertussis
and usual cause of sporadic pertussis
B. parapertussis is an occasional cause ( fewer than 5% of
cases )
These two are exclusive human pathogen (and for some
primates)
B. bronchiseptica is common animal pathogen
Pertussoid syndrome : protracted coughing can also be
caused by Mycoplasma, parainfluenza or influenza viruses,
enteroviruses, RSV & adenoviruses.
6. A E R O S O L A C Q U I S I T I O N O F B
P E R T U S S I S
A T T A C H T O R E S P I R A T O R Y E P I T H .
C E L L S W I T H S U R F A C E
F I L A M E N T O U S H E M A G G L U T I N I N
( F H A ) , F I M B R I A E ( T Y P E S 2 A N D 3 ) &
P E R T A C T I N
P R O D U C E T R A C H E A L C Y T O T O X I N ,
A D E N Y L A T E C Y C L A S E A N D
P E R T U S S I S T O X I N ( P T ) W H I C H
D A M A G E L O C A L E P I T H E L I U M &
E X E R T V A R I O U S B I O L O G I C
A C T I V I T I E S
7. Classically pertussis is divided into :
catarrhal stage- begins after an incubation period
of 3-12 days with symptoms of congestion,
rhinorrhea , low-grade fever, sneezing,
lacrimation, and conjunctivitis (last 1-2wks)
Paroxysmal stage- dry, intermittent, irritative
cough characterized by whoop(forceful inspiratory
gasp) infrequently occurs in infants <3 mo .Post-
tussive emesis is common (lasts for 2-6 wks )
convalescent stage- no. & severity of episodes
decreases over next 1-4 weeks
8. Goals of therapy :
Supportive- give oxygen if cyanosed, proper
nutrition, rest, hydration & avoid stimulation
salbutamol (albuterol) – nebulization may alleviate
symptom(cough suppressants are contraindicated)
Antimicrobial Agents –
1)Erythromycin (40-50 mg/kg/24 hr divided qid)
for 14 days is standard treatment
2)Clarithromycin , azithromycin & co-
trimoxazole are useful alternatives
9. Patients placed in respiratory isolation for ≥5d
Chemoprophylaxis: Erythromycin for 14 days should
be given to all household and other close contacts
Close contacts <7 yr of age who have received less than
four doses of pertussis vaccines should have
vaccination initiated or continued
Prevention : Universal immunization of children <7 yr
of age , beginning in infancy, is central to the control of
pertussis
Combination acellular pertussis (DTaP) vaccines are
preferred over those containing whole-cell pertussis
(DTP) vaccines because of fewer adverse reactions
10.
11. The principal complications of pertussis are
Respiratory complications eg a) bronchieactasis
b) secondary infections ( otitis media,pneumonia)
c) atelectasis ,emphysema &pneumothorax
Sequelae of forceful coughing :(raised pressure)
- conjunctival and scleral hemorrhages
- petechiae on the upper body, epistaxis
- hemorrhage in the CNS and retina
12. -umbilical and inguinal hernias
-rectal prolapse
Neurological complications :
-seizures( several reasons)
-encephalopathy
Malnutrition due to persistent vomiting &
reduced appetite
Flare up of tuberculosis(decrease CMI)
13. Those <2 mo of age have the highest reported rates of
pertussis-associated complications like-
apnea
pneumonia(25%)
seizures (4%)
encephalopathy (1%)
and death (1%)
and so hospitalized in 82% case
Apnea, cyanosis, and secondary bacterial pneumonia
are events precipitating intubation and ventilation
The need for intensive care and artificial ventilation is
usually limited to infants <3 months